Cargando…
Pruritogenic Mediators and New Antipruritic Drugs in Atopic Dermatitis
Atopic dermatitis (AD) is a common highly pruritic chronic inflammatory skin disorder affecting 5–20% of children worldwide, while the prevalence in adults varies from 7 to 10%. Patients with AD experience intense pruritus that could lead to sleep disturbance and impaired quality of life. Here, we a...
Autores principales: | Koumaki, Dimitra, Gregoriou, Stamatios, Evangelou, George, Krasagakis, Konstantinos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10054239/ https://www.ncbi.nlm.nih.gov/pubmed/36983094 http://dx.doi.org/10.3390/jcm12062091 |
Ejemplares similares
-
The Implications of Pruritogens in the Pathogenesis of Atopic Dermatitis
por: Wong, Lai-San, et al.
Publicado: (2021) -
Real-Life Utility of Basophil Activation Test in the Diagnosis of Immediate Hypersensitivity Drug Reactions
por: Koumaki, Dimitra, et al.
Publicado: (2023) -
The IL-4/-13 Axis and Its Blocking in the Treatment of Atopic Dermatitis
por: Pappa, Georgia, et al.
Publicado: (2022) -
The ambiguous pruritogenic role of interleukin-31 in cutaneous T-cell lymphomas in comparison to atopic dermatitis: a review
por: Olszewska, Berenika, et al.
Publicado: (2020) -
Atopic Dermatitis: Striving for Reliable Biomarkers
por: Mastraftsi, Styliani, et al.
Publicado: (2022)